These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 37727457)
1. The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease. Qiu J; Kuang M; Yang R; Yu C; He S; Sheng G; Zou Y Front Endocrinol (Lausanne); 2023; 14():1239398. PubMed ID: 37727457 [TBL] [Abstract][Full Text] [Related]
2. Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population. Qiu J; Kuang M; He S; Yu C; Wang C; Huang X; Sheng G; Zou Y Front Endocrinol (Lausanne); 2023; 14():1302322. PubMed ID: 38125795 [TBL] [Abstract][Full Text] [Related]
3. Association between alanine aminotransferase to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: a retrospective cohort study in lean Chinese individuals. Cao C; Mo Z; Han Y; Luo J; Hu H; Yang D; He Y Sci Rep; 2024 Mar; 14(1):6056. PubMed ID: 38480862 [TBL] [Abstract][Full Text] [Related]
4. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels. Zhu W; Liang A; Shi P; Yuan S; Zhu Y; Fu J; Zheng T; Wen Z; Wu X BMC Gastroenterol; 2022 Apr; 22(1):196. PubMed ID: 35448944 [TBL] [Abstract][Full Text] [Related]
5. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. Yang S; Zhong J; Ye M; Miao L; Lu G; Xu C; Xue Z; Zhou X Lipids Health Dis; 2020 Nov; 19(1):242. PubMed ID: 33222696 [TBL] [Abstract][Full Text] [Related]
6. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents. Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791 [TBL] [Abstract][Full Text] [Related]
7. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y. Li XD; Qiu BH; Su FC; Sun SX Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771 [TBL] [Abstract][Full Text] [Related]
8. Analysis of risk factors for non-alcoholic fatty liver disease in hospitalized children with obesity before the late puberty stage. Zhou L; Zhang L; Zhang L; Yi W; Yu X; Mei H; Xiao H; Wang Y; Qin H; Xiong X; Yan S; Dong H; Chen P; Chen X Front Endocrinol (Lausanne); 2023; 14():1224816. PubMed ID: 37720532 [TBL] [Abstract][Full Text] [Related]
9. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study. Zou Y; Zhong L; Hu C; Sheng G Lipids Health Dis; 2020 Nov; 19(1):245. PubMed ID: 33239040 [TBL] [Abstract][Full Text] [Related]
10. Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States. Xuan Y; Wu D; Zhang Q; Yu Z; Yu J; Zhou D Front Endocrinol (Lausanne); 2024; 15():1457598. PubMed ID: 39253584 [TBL] [Abstract][Full Text] [Related]
11. Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome. Sogabe M; Okahisa T; Kurihara T; Takehara M; Kagemoto K; Okazaki J; Kida Y; Hirao A; Tanaka H; Tomonari T; Taniguchi T; Okamoto K; Nakasono M; Takayama T PLoS One; 2020; 15(8):e0238388. PubMed ID: 32866186 [TBL] [Abstract][Full Text] [Related]
12. The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. Fu CC; Chen MC; Li YM; Liu TT; Wang LY Ann Acad Med Singap; 2009 Jan; 38(1):15-7. PubMed ID: 19221666 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and associated metabolic factors of fatty liver disease in the elderly. Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951 [TBL] [Abstract][Full Text] [Related]
14. A combined association of serum uric acid, alanine aminotransferase and waist circumference with non-alcoholic fatty liver disease: a community-based study. Wang M; Wang M; Zhang R; Zhang L; Ding Y; Tang Z; Fan H; Wang H; Zhang W; Chen Y; Wang J PeerJ; 2022; 10():e13022. PubMed ID: 35265397 [TBL] [Abstract][Full Text] [Related]
15. Estimated Prevalence of Adolescents with Nonalcoholic Fatty Liver Disease in Korea. Kang Y; Park S; Kim S; Koh H J Korean Med Sci; 2018 Apr; 33(14):e109. PubMed ID: 29607635 [TBL] [Abstract][Full Text] [Related]
16. Remnant cholesterol/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease. Zou Y; Hu C; Kuang M; Chai Y BMC Gastroenterol; 2022 Mar; 22(1):134. PubMed ID: 35331166 [TBL] [Abstract][Full Text] [Related]
17. Association between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. Huang H; Wang Q; Shi X; Chen Y; Shen C; Zhang J; Xu C Mediators Inflamm; 2021; 2021():6642246. PubMed ID: 34916874 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD. Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268 [TBL] [Abstract][Full Text] [Related]
19. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population. Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004 [TBL] [Abstract][Full Text] [Related]
20. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound. Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]